These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22751117)

  • 1. RET is a potential tumor suppressor gene in colorectal cancer.
    Luo Y; Tsuchiya KD; Il Park D; Fausel R; Kanngurn S; Welcsh P; Dzieciatkowski S; Wang J; Grady WM
    Oncogene; 2013 Apr; 32(16):2037-47. PubMed ID: 22751117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infrequent detectable somatic mutations of the RET and glial cell line-derived neurotrophic factor (GDNF) genes in human pituitary adenomas.
    Yoshimoto K; Tanaka C; Moritani M; Shimizu E; Yamaoka T; Yamada S; Sano T; Itakura M
    Endocr J; 1999 Feb; 46(1):199-207. PubMed ID: 10426588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers.
    Li H; Myeroff L; Smiraglia D; Romero MF; Pretlow TP; Kasturi L; Lutterbaugh J; Rerko RM; Casey G; Issa JP; Willis J; Willson JK; Plass C; Markowitz SD
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8412-7. PubMed ID: 12829793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer.
    Rojas A; Meherem S; Kim YH; Washington MK; Willis JE; Markowitz SD; Grady WM
    Int J Cancer; 2008 Jul; 123(1):14-21. PubMed ID: 18425817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer.
    Kim YH; Petko Z; Dzieciatkowski S; Lin L; Ghiassi M; Stain S; Chapman WC; Washington MK; Willis J; Markowitz SD; Grady WM
    Genes Chromosomes Cancer; 2006 Aug; 45(8):781-9. PubMed ID: 16708352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer.
    Akino K; Toyota M; Suzuki H; Mita H; Sasaki Y; Ohe-Toyota M; Issa JP; Hinoda Y; Imai K; Tokino T
    Gastroenterology; 2005 Jul; 129(1):156-69. PubMed ID: 16012945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent inactivation of axon guidance molecule RGMA in human colon cancer through genetic and epigenetic mechanisms.
    Li VS; Yuen ST; Chan TL; Yan HH; Law WL; Yeung BH; Chan AS; Tsui WY; So S; Chen X; Leung SY
    Gastroenterology; 2009 Jul; 137(1):176-87. PubMed ID: 19303019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Inactivation of α-Internexin Accelerates Microtubule Polymerization in Colorectal Cancer.
    Li Y; Bai L; Yu H; Cai D; Wang X; Huang B; Peng S; Huang M; Cao G; Kaz AM; Grady WM; Wang J; Luo Y
    Cancer Res; 2020 Dec; 80(23):5203-5215. PubMed ID: 33051252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancer.
    Luo Y; Kaz AM; Kanngurn S; Welsch P; Morris SM; Wang J; Lutterbaugh JD; Markowitz SD; Grady WM
    PLoS Genet; 2013; 9(7):e1003552. PubMed ID: 23874207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors.
    Marsh DJ; Zheng Z; Arnold A; Andrew SD; Learoyd D; Frilling A; Komminoth P; Neumann HP; Ponder BA; Rollins BJ; Shapiro GI; Robinson BG; Mulligan LM; Eng C
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3025-8. PubMed ID: 9284737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling.
    Sawai H; Okada Y; Kazanjian K; Kim J; Hasan S; Hines OJ; Reber HA; Hoon DS; Eibl G
    Cancer Res; 2005 Dec; 65(24):11536-44. PubMed ID: 16357163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines.
    Lopes EC; Valls E; Figueroa ME; Mazur A; Meng FG; Chiosis G; Laird PW; Schreiber-Agus N; Greally JM; Prokhortchouk E; Melnick A
    Cancer Res; 2008 Sep; 68(18):7258-63. PubMed ID: 18794111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway.
    Sakai E; Fukuyo M; Ohata K; Matsusaka K; Doi N; Mano Y; Takane K; Abe H; Yagi K; Matsuhashi N; Fukushima J; Fukayama M; Akagi K; Aburatani H; Nakajima A; Kaneda A
    Int J Cancer; 2016 Apr; 138(7):1634-44. PubMed ID: 26510091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.
    Bond CE; Bettington ML; Pearson SA; McKeone DM; Leggett BA; Whitehall VL
    BMC Cancer; 2015 Jan; 15():20. PubMed ID: 25613750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly methylated genes in colorectal neoplasia: implications for screening.
    Zou H; Harrington JJ; Shire AM; Rego RL; Wang L; Campbell ME; Oberg AL; Ahlquist DA
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2686-96. PubMed ID: 18086775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps.
    Petko Z; Ghiassi M; Shuber A; Gorham J; Smalley W; Washington MK; Schultenover S; Gautam S; Markowitz SD; Grady WM
    Clin Cancer Res; 2005 Feb; 11(3):1203-9. PubMed ID: 15709190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
    Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
    World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular RET signaling pathways activated by GDNF.
    Kawai K; Takahashi M
    Cell Tissue Res; 2020 Oct; 382(1):113-123. PubMed ID: 32816064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers.
    Park HW; Kang HC; Kim IJ; Jang SG; Kim K; Yoon HJ; Jeong SY; Park JG
    Int J Cancer; 2007 Jan; 120(1):7-12. PubMed ID: 17013898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
    Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
    Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.